The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 30 | — | 20.1x | Below average | |
Growth | 41 | -10.6% | 5.6% | Near average | |
Quality | 37 | -159.7% | 7.6% | Near average | |
Safety | 33 | 0.4x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Cardiff Oncology, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Cardiff Oncology, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Cardiff Oncology stock shows a state of cautious stability in target prices at the $2 level, with total consensus among the three analysts covering the stock (zero dispersion). Although the target price represents a 42% premium over the current price ($1.4), general confidence has seen a qualitative decline recently; Craig-Hallum downgraded the stock from 'Buy' to 'Hold' in June 2026, indicating a shift in outlook from absolute optimism to anticipation.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.